211 related articles for article (PubMed ID: 27839916)
1. Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.
Hong JH; Kim YK; Park JS; Lee JE; Oh MS; Chung EJ; Kim JY; Sung YH; Lyoo CH; Lee JH; Kwon DY; Kim HS; Shin HW; Park SA; Park IS; Kim JS; Lee PH; Koh SB; Baik JS; Kim SJ; Ma HI; Kim JW; Kim YJ
J Clin Neurosci; 2017 Feb; 36():108-113. PubMed ID: 27839916
[TBL] [Abstract][Full Text] [Related]
2. LRRK2-associated Parkinson's disease patients have better stereopsis than idiopathic Parkinson disease.
Sun L; Chan P
Clin Neurol Neurosurg; 2018 Jun; 169():174-177. PubMed ID: 29705653
[TBL] [Abstract][Full Text] [Related]
3. Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease.
Cui SS; Fu R; Du JJ; Lin YQ; Huang P; Gao C; Zhou HY; Chen SD
BMC Neurosci; 2021 Mar; 22(1):22. PubMed ID: 33771108
[TBL] [Abstract][Full Text] [Related]
4. Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.
Cao M; Gu ZQ; Li Y; Zhang H; Dan XJ; Cen SS; Li DW; Chan P
Neurosci Bull; 2016 Dec; 32(6):572-576. PubMed ID: 27699718
[TBL] [Abstract][Full Text] [Related]
5. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
[TBL] [Abstract][Full Text] [Related]
6. Fatigue correlates with LRRK2 G2385R variant in Chinese Parkinson's disease patients.
Fu R; Cui SS; Du JJ; He YC; Gao C; Huang P; Qian YW; Luo XG; Chen SD
Parkinsonism Relat Disord; 2017 Nov; 44():101-105. PubMed ID: 28941828
[TBL] [Abstract][Full Text] [Related]
7. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
Marras C; Alcalay RN; Caspell-Garcia C; Coffey C; Chan P; Duda JE; Facheris MF; Fernández-Santiago R; Ruíz-Martínez J; Mestre T; Saunders-Pullman R; Pont-Sunyer C; Tolosa E; Waro B;
Mov Disord; 2016 Aug; 31(8):1192-202. PubMed ID: 27091104
[TBL] [Abstract][Full Text] [Related]
8. Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.
Ben Sassi S; Nabli F; Hentati E; Nahdi H; Trabelsi M; Ben Ayed H; Amouri R; Duda JE; Farrer MJ; Hentati F
Parkinsonism Relat Disord; 2012 Mar; 18(3):243-6. PubMed ID: 22056842
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.
Liu SY; Zheng Z; Gu ZQ; Wang CD; Tang BS; Xu YM; Ma JH; Zhou YT; Feng T; Chen SD; Chan P;
Parkinsonism Relat Disord; 2018 Dec; 57():72-76. PubMed ID: 30119933
[TBL] [Abstract][Full Text] [Related]
10. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.
Ortega RA; Wang C; Raymond D; Bryant N; Scherzer CR; Thaler A; Alcalay RN; West AB; Mirelman A; Kuras Y; Marder KS; Giladi N; Ozelius LJ; Bressman SB; Saunders-Pullman R
JAMA Netw Open; 2021 Apr; 4(4):e215845. PubMed ID: 33881531
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
12. A 10-Year Community-Based Study of Leucine-Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease.
Wang P; Pan J; Luo Q; Chen J; Tang H; Chen S; Ma J
Mov Disord; 2022 Aug; 37(8):1767-1772. PubMed ID: 35733392
[TBL] [Abstract][Full Text] [Related]
13. The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2.
Rudenko IN; Kaganovich A; Langston RG; Beilina A; Ndukwe K; Kumaran R; Dillman AA; Chia R; Cookson MR
Biochem J; 2017 Apr; 474(9):1547-1558. PubMed ID: 28320779
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.
Gao C; Pang H; Luo XG; Ren Y; Shang H; He ZY
J Neurol; 2013 Nov; 260(11):2884-9. PubMed ID: 24046064
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of PD patients with LRRK2 G2385R and R1628P variants.
Liang D; Shu L; Pan H; Xu Q; Guo J; Yan X; Tang B; Sun Q
Neurosci Lett; 2018 Oct; 685():185-189. PubMed ID: 30121215
[TBL] [Abstract][Full Text] [Related]
16. The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.
Xie CL; Pan JL; Wang WW; Zhang Y; Zhang SF; Gan J; Liu ZG
Neurol Sci; 2014 Oct; 35(10):1495-504. PubMed ID: 25027012
[TBL] [Abstract][Full Text] [Related]
17. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
[TBL] [Abstract][Full Text] [Related]
18. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
[TBL] [Abstract][Full Text] [Related]
19. CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.
Loeffler DA; Smith LM; Coffey MP; Aasly JO; LeWitt PA
J Neural Transm (Vienna); 2016 Mar; 123(3):179-87. PubMed ID: 26526034
[TBL] [Abstract][Full Text] [Related]
20. Progression in the LRRK2-Asssociated Parkinson Disease Population.
Saunders-Pullman R; Mirelman A; Alcalay RN; Wang C; Ortega RA; Raymond D; Mejia-Santana H; Orbe-Reilly M; Johannes BA; Thaler A; Ozelius L; Orr-Urtreger A; Marder KS; Giladi N; Bressman SB;
JAMA Neurol; 2018 Mar; 75(3):312-319. PubMed ID: 29309488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
